Regenerative Medical Technology Group Inc. RMTG
Set alert
As of Nov 2, 12:12 PM ET
- YTD
- -28.57%
- 1 year
- -28.93%
- Open
- 0.035
- Prev close
- 0.031
- Mkt cap
- 480.86K
- Vol
- 10.00K
- Avg vol
- 55.91K
- EPS
- -0.70
- P/E
- 0.00
More statistics
- Low
- 0.035
- High
- 0.035
News
1 week ago accessnewswire.com
RMTG's ISSCA Division Returns to São Paulo for a Second Brazil Congress, November 20-21
A second Brazil event in a single year - a frequency ISSCA has not previously applied - underscores Brazil's priority alongside Cellgenic's permanent operations there. MIAMI, FL / ACCESS Newswire /…
1 week ago accessnewswire.com
RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
MIAMI, FL / ACCESS Newswire / October 20, 2026 / Regenerative Medical Technology Group Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned…
3 weeks ago accessnewswire.com
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
A digital-first expansion scales physician education beyond ISSCA's in-person markets, diversifying the education segment toward higher-margin, travel-independent revenue. MIAMI, FL / ACCESS Newswire…
4 weeks ago accessnewswire.com
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing. MIAMI, FL /…
1 month ago accessnewswire.com
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
The upgraded program complements Cellgenic's expanding peptide training product portfolio and is intended as a current example of RMTG's education-to-product operating model. MIAMI, FL / ACCESS…
1 month ago accessnewswire.com
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
Training Business Accelerates with Hundreds of Physicians from over 50 Countries at our Flagship Cancún Global Summit. ISSCA 125 Global Summit is scheduled to combine five ISSCA certification tracks…
1 month ago accessnewswire.com
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
ISSCA's most comprehensive credential to date integrates regenerative medicine, biotechnology, longevity medicine, and artificial intelligence - a durable, multi-year physician-relationship asset.…
1 month ago accessnewswire.com
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
Physician-controlled lab-to-plan workflow, ISSCA protocol ingestion, licensed technology partnership, and clinic-facing SaaS and membership design - with the physician remaining the decision-maker…
1 month ago accessnewswire.com
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
Colombia is the third Latin American market in which Cellgenic has recently announced local commercial arrangements. Activity remains subject to applicable Colombian law and the terms of local…
2 months ago accessnewswire.com
Cellgenic Establishes Local Commercial Presence in Brazil
Cellgenic is expanding local representation and commercial support in Brazil, one of Latin America's larger healthcare and aesthetic-medicine markets. ISSCA continues to hold physician-education…
2 months ago accessnewswire.com
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
Peru becomes the newest addition to Cellgenic's Latin American commercial network - one of three coordinated market initiatives across the region, subject to applicable local regulatory requirements.…
2 months ago accessnewswire.com
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
A second cellular-technology launch in close succession broadens Cellgenic's portfolio into Latin America, the Middle East, Europe, and Southeast Asia, demonstrating a repeatable product-development…
2 months ago accessnewswire.com
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
New Website Serves as a Central Source for Investor Information and Timely Disclosure; Investor Inquiries Directed to ir@rmtg.com MIAMI, FL / ACCESS Newswire / August 26, 2026 / Regenerative Medical…
2 months ago accessnewswire.com
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
New NK cell platform extends RMTG's cellular-technology portfolio into immunology-adjacent applications, with an initial commercial focus on Latin America and Southeast Asia. MIAMI, FL / ACCESS…
2 months ago accessnewswire.com
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
Continued Acceleration in 2026 With Record Revenue, Expanding Margins, Growth in Operating Profit, and Accelerating Training and Product Supply Sales MIAMI, FL / ACCESS Newswire / August 20, 2026 /…
2 months ago accessnewswire.com
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
Company Announces Date, Time and Connection Details for Its Inaugural Investor Call Following a Strong First Half of 2026 MIAMI, FL / ACCESS Newswire / August 19, 2026 / Regenerative Medical…
2 months ago accessnewswire.com
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
An owned-infrastructure investment adds manufacturing, quality-systems, and product-development capacity to support Cellgenic's growing international product portfolio. MIAMI, FL / ACCESS Newswire /…
2 months ago accessnewswire.com
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
A Positive First Half of 2026 Prompts the Company to Launch Its First Investor Call and Invite Shareholder Questions MIAMI, FL / ACCESS Newswire / August 5, 2026 / Regenerative Medical Technologies…
3 months ago accessnewswire.com
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
Cellgenic Launches Regulated Commercial Operations in Argentina, Creating a Platform for Biologics Distribution, Physician Education, and Regional Expansion Across Latin America MIAMI, FL / ACCESS…
4 months ago accessnewswire.com
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
New AI Platform Builds on a 30+ Country Physician Network and the ISSCA Mobile App to Create a Connected, Technology-Enabled Ecosystem for Regenerative and Longevity Medicine MIAMI, FL / ACCESS…